Clinical Trial

Spine Deformity Patients With Optoelectronic Motion Capture

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Aging-induced changes in the spine can lead to adult spinal deformity, causing a forward and/or lateral shift of the trunk. While mild cases may have compensatory mechanisms, severe deformities necessitate treatment. Surgery with instrumentation effectively corrects deformities, but complications are common. Precise pre-operative planning based on X-rays is essential. However, radiological imaging has limitations, including ionizing radiation exposure and static nature. Marker-based optoelectronic motion analysis systems offer potential benefits for dynamic spine assessment. This study aims to test the feasibility of using motion analysis systems to characterize spinal alignment and balance in patients with adult spine deformity. The primary objective is to assess the practical implementation, measurement capability, and resources required for motion analysis. Secondary objectives include investigating errors in absolute spinal curvature assessment and developing compensation strategies. The project will recruit 20 patients (non-operated and operated) seeking medical attention for adult spine deformities and 10 healthy controls. Participants will undergo biplanar imaging and motion analysis to capture static and dynamic spine alignment during common activities. The data will help build patient-specific musculoskeletal models, offering potential insights into improving surgical planning for adult spine deformities.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-01-16.
Trial Details
NCT Number NCT06223737
Lead Sponsor Schulthess Klinik
Collaborators: ETH Zurich, Bern University of Applied Sciences
Conditions Spine Deformity
Enrollment 30 participants
Start Date 2025-05-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-29